Shareholders
Shareholders

Alberto Daniel Serventich

Laboratorios Richmond shareholder with documented involvement in the company’s governance and audit oversight.

Value of known holdings
≈ 18.58B ARS
Companies valued
1 of 1

About the shareholder

In 2019, he signed the audit committee report as its chairman. In December 2024, the company announced his sale of part of his shares to Marcelo Figueiras; the March 2026 accounts retain a Serventich holding. Historical roles and changes to the stake are recorded separately.

Verified companies

Value of the stake
≈ 18.58B ARS

Stake included: 15.24% ·

As of Class A
Capital
15.24%
Voting rights
—

Source: Laboratorios Richmond · estructura accionaria al 30/09/2025 · Retrieved Sep 29, 2026

Capital stake × market capitalization in ARS. Only the latest disclosure per company is counted. Dates differ; this is not the owner’s total wealth.

Market-cap data retrieved

Capital ownership and voting rights are different measures. “—” means unavailable, not zero.

Sources: Laboratorios Richmond · Acta de directorio · 9 diciembre 2024 · Laboratorios Richmond · Estados contables · marzo 2026 · Laboratorios Richmond · Comité de auditoría · 2019

A view of the market.
With full transparency.

Closing prices and daily history from BYMA Open Data. These are not real-time quotes.

Quote sourceBYMA Open DataLatest available sessionOct 02, 2026Last fetchedOct 3, 2026, 04:27 AM GMT-3CurrencyARSSettlementT+1 · 24hsCoverage133 / 258

Daily history is kept as supplied by BYMA. Symbols without data show no quote. Dates may differ between stocks. Corporate-action adjustments are not independently verified.

Financial data

Financial statements, multiples and estimates. Availability varies by instrument. Profiles and shareholders show their sources and dates.

Last fetched: Oct 03, 2026

La Plata is independent. Commercial data publication requires reviewing BYMA terms.